Updates are available Correction dated 2019-10-22
Click to view Correction: https://doi.org/10.1186/s12885-019-6223-y
-
Authors
Verdonck-de Leeuw, I.M. https://orcid.org/0000-0002-4507-4607
Jansen, F.
Brakenhoff, R. H.
Langendijk, J. A.
Takes, R.
Terhaard, C. H. J.
Baatenburg de Jong, R. J.
Smit, J. H.
Leemans, C. R.
-
Funding
Funding for this research was provided by:
Dutch Cancer Society (VU 2013-5930)
- License Information
-
More Information
Article History
Received: 20 May 2019
Accepted: 24 June 2019
First Online: 5 August 2019
Change Date: 22 October 2019
Change Type: Correction
Change Details: Following publication of the original article [1], the authors reported the name of R.J. Baatenburg de Jong was incorrectly tagged in the HTML version of the article.
Ethics approval and consent to participate
: The study protocol has been approved by the Institutional Review Board of the coordinating research center (Amsterdam UMC (location VUmc)) (2013.301(A2018.307)-NL45051.029.13). Participants provided written informed consent to use and re-use their data and samples in future studies that aim to research HRQOL and improved diagnosis and treatment of HNC. The NET-QUBIC Research Agreement is signed by all participating hospitals.
: Not applicable.
: The authors declare that they have no competing interests.
